We are live on ! Find out more
TECX

Tectonic Therapeutic

64 hedge funds and large institutions have $23.8M invested in Tectonic Therapeutic in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.66% less ownership

Funds ownership: 5.6%4.94% (-0.66%)

19% less funds holding

Funds holding: 7964 (-15)

39% less capital invested

Capital invested by funds: $38.8M → $23.8M (-$14.9M)

46% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 26

54% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 26

Holders
64
Holders Change
-15
Holders Change %
-18.99%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
12
Reduced
26
Closed
26
Calls
$26K
Puts
Net Calls
+$26K
Net Calls Change
-$160K

TECX Hedge Fund Activity: Q2 2022 in Review

64 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2022, worth a combined $23.8M — down 39% from $38.8M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TECX and 14 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 12 added.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $1.1M. The largest seller was Federated Hermes, cutting an estimated $2.4M.

  • 64 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2022, down from 79 in Q1 2022.
  • Funds reported $23.8M of Tectonic Therapeutic stock for Q2 2022, down 39% quarter-over-quarter.
  • 14 funds opened new Tectonic Therapeutic positions in Q2 2022 and 26 closed out, a net change of -12 holders.
  • The largest Tectonic Therapeutic buyer in Q2 2022 was K2 Principal Fund, an estimated $1.1M added.
  • The largest Tectonic Therapeutic seller in Q2 2022 was Federated Hermes, an estimated $2.4M sold.

Based on aggregated 13F filings for Q2 2022.